 |

Arbor Vita is a biopharmaceutical company focused
on the discovery, development and commercialization of novel drugs and
diagnostics addressing disease through a new family of targets, PDZ proteins.
PDZ proteins are critical elements that organize and regulate many signaling
pathways in human cells. The disruption of PDZ interactions has recently
begun to be appreciated as providing a novel way to control multiple signaling
cascades in complex diseases. Arbor Vita is pioneering the development
of therapeutics and diagnostics through their unique understanding of
the role of PDZs in cell signaling and disease. The company is tackling
major health issues including cancer; infectious diseases such as influenza;
stroke and cardiovascular disease. |

|
 |
|

 |
Special Report
February 27, 2007
Arbor Vita Cervical Cancer Diagnostic Featured on Fox News |
 |
 |
|
 |